Velosbio Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

This study tested an experimental drug called VLS-101 in 102 people with advanced solid tumors, including breast, lung, ovarian, stomach, and pancreatic cancers that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors. However, the t…